Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

First-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma—commentary on patient-reported outcomes in EV-302

Liedberg, Fredrik LU ; Ståhl, Olof LU and Bobjer, Johannes LU (2026) In Translational Andrology and Urology 15(1).
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
health-related quality of life, locally advanced, metastatic, patient-reported outcomes, Urothelial carcinoma
in
Translational Andrology and Urology
volume
15
issue
1
article number
8
publisher
AME Publishing Company
external identifiers
  • pmid:41658467
  • scopus:105028851754
ISSN
2223-4683
DOI
10.21037/tau-2025-733
language
English
LU publication?
yes
id
ac10eb36-dff2-46d6-a901-1192ac195eb3
date added to LUP
2026-02-19 12:58:33
date last changed
2026-02-20 03:00:08
@misc{ac10eb36-dff2-46d6-a901-1192ac195eb3,
  author       = {{Liedberg, Fredrik and Ståhl, Olof and Bobjer, Johannes}},
  issn         = {{2223-4683}},
  keywords     = {{health-related quality of life; locally advanced; metastatic; patient-reported outcomes; Urothelial carcinoma}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{AME Publishing Company}},
  series       = {{Translational Andrology and Urology}},
  title        = {{First-line enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma—commentary on patient-reported outcomes in EV-302}},
  url          = {{http://dx.doi.org/10.21037/tau-2025-733}},
  doi          = {{10.21037/tau-2025-733}},
  volume       = {{15}},
  year         = {{2026}},
}